BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23323457)

  • 1. [Usefulness of hepatitis C virus (HCV) genotype test using direct sequencing of 5' untranslated region--application from 2003 to 2011].
    Maruo R; Sato Y; Yokota H; Kageyama Y; Syukuya K; Yatomi Y
    Rinsho Byori; 2012 Oct; 60(10):927-31. PubMed ID: 23323457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a better resolution of hepatitis C virus variants: CLIP sequencing of an HCV core fragment and automated assignment of genotypes and subtypes.
    Ross RS; Viazov S; Wolters B; Roggendorf M
    J Virol Methods; 2008 Mar; 148(1-2):25-33. PubMed ID: 18053586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan.
    Idrees M
    J Virol Methods; 2008 Jun; 150(1-2):50-6. PubMed ID: 18423633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ
    J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.
    Buckton AJ; Ngui SL; Arnold C; Boast K; Kovacs J; Klapper PE; Patel B; Ibrahim I; Rangarajan S; Ramsay ME; Teo CG
    J Clin Microbiol; 2006 Aug; 44(8):2779-84. PubMed ID: 16891492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping.
    Ilina EN; Malakhova MV; Generozov EV; Nikolaev EN; Govorun VM
    J Clin Microbiol; 2005 Jun; 43(6):2810-5. PubMed ID: 15956402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the invader assay for genotyping hepatitis C virus.
    Germer JJ; Majewski DW; Yung B; Mitchell PS; Yao JD
    J Clin Microbiol; 2006 Feb; 44(2):318-23. PubMed ID: 16455877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
    Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
    J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences.
    Win NN; Nakamoto S; Kanda T; Takahashi H; Takahashi-Nakaguchi A; Yasui S; Nakamura M; Wu S; Imazeki F; Mikami S; Yokosuka O; Gonoi T; Shirasawa H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real-time Taqman method for hepatitis C virus genotyping.
    Rolfe KJ; Alexander GJ; Wreghitt TG; Parmar S; Jalal H; Curran MD
    J Clin Virol; 2005 Oct; 34(2):115-21. PubMed ID: 15893957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of HCV genotype by direct sequence analysis of quantitative PCR products.
    Gargiulo F; De Francesco MA; Pinsi G; Pollara C; Terlenghi L; Perandin F; Manca N
    J Med Virol; 2003 Feb; 69(2):202-6. PubMed ID: 12683408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
    Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
    J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatitis C virus subtyping by ns5b sequencing with 5'utr based methods.
    Pagani E; Huemer HP; Pasquetto V; Cemin C; Molon L; Rossi P; Larcher C
    Minerva Med; 2012 Aug; 103(4):293-7. PubMed ID: 22805621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorimetric oligonucleotide array for genotyping of hepatitis C virus based on the 5' non-coding region.
    Mao H; Lu Z; Zhang H; Liu K; Zhao J; Jin G; Gu S; Yang M
    Clin Chim Acta; 2008 Feb; 388(1-2):22-7. PubMed ID: 17976565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three different hepatitis C virus typing methods for detection of mixed-genotype infections.
    Idrees M; Ur Rehman I; Manzoor S; Akbar H; Butt S; Afzal S; Yousaf MZ; Hussain A
    J Dig Dis; 2011 Jun; 12(3):199-203. PubMed ID: 21615874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
    J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of line probe assay and DNA sequencing of 5' untranslated region for genotyping hepatitis C virus: description of novel line probe patterns.
    Mitchell PS; Sloan LM; Majewski DW; Rys PN; Heimgartner PJ; Rosenblatt JE; Cockerill FR; Smith TF; Patel R
    Diagn Microbiol Infect Dis; 2002 Mar; 42(3):175-9. PubMed ID: 11929688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b.
    Chen Z; Weck KE
    J Clin Microbiol; 2002 Sep; 40(9):3127-34. PubMed ID: 12202542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.